QUESTION NO: 1
A drug product presents degradation during the manufacturing process. In addition to the amount, what information should be provided FIRST in order to use API overage?
A drug product presents degradation during the manufacturing process. In addition to the amount, what information should be provided FIRST in order to use API overage?
Correct Answer: B
Vote an answer
QUESTION NO: 2
As a member of the product launch review committee, a regulatory affairs professional discovers a major issue with the labeling of a product prior to production. In addition to informing the committee, which is the BEST approach to address the issue?
As a member of the product launch review committee, a regulatory affairs professional discovers a major issue with the labeling of a product prior to production. In addition to informing the committee, which is the BEST approach to address the issue?
Correct Answer: B
Vote an answer
QUESTION NO: 3
A company is developing a new product for the global market. A new international guideline will recommend relevant studies in the pediatric population, and the guideline will be effective before the approval of the company's new product.
What is the BEST advice the regulatory affairs professional can provide to minimize the impact of this guideline on the successful registration of the new product?
A company is developing a new product for the global market. A new international guideline will recommend relevant studies in the pediatric population, and the guideline will be effective before the approval of the company's new product.
What is the BEST advice the regulatory affairs professional can provide to minimize the impact of this guideline on the successful registration of the new product?
Correct Answer: A,B
Vote an answer
QUESTION NO: 4
What is the LAST stage in the development of a quality risk management process for a medical device?
What is the LAST stage in the development of a quality risk management process for a medical device?
Correct Answer: B
Vote an answer
QUESTION NO: 5
Which of the following double-blind clinical trial designs would be MOST appropriate for a Phase III study with a new product intended to treat an acute life-threatening disease with less than optimal available therapy?
Which of the following double-blind clinical trial designs would be MOST appropriate for a Phase III study with a new product intended to treat an acute life-threatening disease with less than optimal available therapy?
Correct Answer: C
Vote an answer
QUESTION NO: 6
During face-to-face meetings with the regulatory authority to address submission issues, what is the BEST choice for the number of company representatives who should attend?
During face-to-face meetings with the regulatory authority to address submission issues, what is the BEST choice for the number of company representatives who should attend?
Correct Answer: C
Vote an answer
QUESTION NO: 7
Which of the following statements regarding the off-label use of drugs is CORRECT?
Which of the following statements regarding the off-label use of drugs is CORRECT?
Correct Answer: C
Vote an answer
QUESTION NO: 8
In which section of the ICH Common Technical Document will the overview of clinical data appear?
In which section of the ICH Common Technical Document will the overview of clinical data appear?
Correct Answer: B,D
Vote an answer
QUESTION NO: 9
According to ICH, which of the following components of study information is NOT required in a clinical study report?
According to ICH, which of the following components of study information is NOT required in a clinical study report?
Correct Answer: B
Vote an answer
QUESTION NO: 10
In preparation for the development of a new line of products, a regulatory affairs professional is asked to prepare a short presentation for senior management. Which of the following topics is MOST important to cover?
In preparation for the development of a new line of products, a regulatory affairs professional is asked to prepare a short presentation for senior management. Which of the following topics is MOST important to cover?
Correct Answer: D
Vote an answer